We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Exciva Stock

Invest in or calculate the value of your shares in Exciva or other pre-IPO companies through EquityZen's platform.

Get Started

Exciva Stock

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

About Exciva Stock

Founded

2015

Industries

Travel and Tourism, Space, Transportation

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia, including agitation and aggression in Alzheimer’s disease. It applies a targeted drug rescue approach that identifies and repurposes previously approved or clinically tested compounds into new therapeutic candidates. Exciva conducts scientific research and clinical studies to evaluate safety and potential effectiveness of its investigational products in neuropsychiatry. Its programs include formulations and methods designed for symptomatic relief and improved behavioral outcomes. Exciva collaborates with scientific and medical professionals to advance its pipeline through regulated trial phases and regulatory processes.

Exciva Management

Leadership team at Exciva

Board Member

Raphaël Wisniewski

Board Member

Stefanie Wojciech

Locked Features

Join now and verify your accreditation status to gain access to:

  • Exciva Current Valuation
  • Exciva Stock Price
  • Exciva Management
  • Available deals in Exciva and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Exciva Cap Table and Funding History by Share Class and Liquidity Preferences
    • Exciva Revenue and Financials
    • Exciva Highlights
    • Exciva Business Model
    • Exciva Risk Factors
  • Exciva Research Report from SACRA Research
Join Now

Trading Exciva Stock

How to invest in Exciva stock?

Accredited investors can buy pre-IPO stock in companies like Exciva through EquityZen funds. These investments are made available by existing Exciva shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Exciva stock?

Shareholders can sell their Exciva stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Exciva